Karaja Biosciences
Karaja Biosciences uses artificial intelligence to design phage therapies that target bacterial infections. The company leverages AI, phage biology, and genomics to develop therapies for clinical use. Category: B2B biopharma focused on partnering with healthcare providers and researchers. The approach enables antimicrobial development through AI-driven discovery and collaboration. The company aims to scale through partnerships and clinical programs in infectious disease therapeutics.
Karaja Biosciences
Karaja Biosciences uses artificial intelligence to design phage therapies that target bacterial infections. The company leverages AI, phage biology, and genomics to develop therapies for clinical use. Category: B2B biopharma focused on partnering with healthcare providers and researchers. The approach enables antimicrobial development through AI-driven discovery and collaboration. The company aims to scale through partnerships and clinical programs in infectious disease therapeutics.